Results 251 to 260 of about 48,636 (310)

Engineered Elastin‐Like Polypeptides: Intelligent Self‐Assembling Platforms for Biomedical Application

open access: yesSmall Structures, Volume 7, Issue 3, March 2026.
Armed with unique structural and functional properties, elastin‐like polypeptides attract their attentions as programmable materials in biomedical applications, including fusion tags for protein and nucleic acid purification; nanocarriers for protein, chemotherapeutics, and imaging agent delivery; hydrogels for tissue regeneration, 3D model ...
Yang Yuan   +9 more
wiley   +1 more source

Concurrent Development of B‐Cell Lymphoblastic Lymphoma and Histiocytic Sarcoma in a C57BL/6 Laboratory Mouse: A Case Report

open access: yesVeterinary Medicine and Science, Volume 12, Issue 2, March 2026.
This study describes a rare concurrent tumour composed of B‐cell lymphoblastic lymphoma and histiocytic sarcoma in a laboratory mouse. The two neoplastic components were clearly distinguished by distinct histopathological features and immunophenotypes, with CD20 and Pax5 expression in the lymphoblastic population and Iba1 positivity in the histiocytic ...
Yujeong Lee   +6 more
wiley   +1 more source

The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia. [PDF]

open access: yesJ Clin Med
Candan O   +10 more
europepmc   +1 more source

Evaluation of multi-antigen targeting ADCC strategies in pediatric BCP-ALL. [PDF]

open access: yesJ Immunother Cancer
Grain A   +10 more
europepmc   +1 more source

Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome: an extended follow-up. [PDF]

open access: yesFront Immunol
Colucci M   +10 more
europepmc   +1 more source

Causal relationship between immune cells and idiopathic thrombocytopenic purpura: A bidirectional Mendelian randomization study

open access: yes
Rheumatology &Autoimmunity, Volume 6, Issue 1, Page 63-65, March 2026.
Heyi Zhang   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy